⌘K
Loading ticker…
As of 2026-08-24, DexCom, Inc. (DXCM) has a 3-month relative strength percentile of 85 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 58. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.1%, relative volume 0.77×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
DXCM is in a stage 2 uptrend, week 5. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 16.8% / 31.1%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
DXCM is held by 94 ETFs as of May 2026. Top owner: QQQM at 0.12% weight, $121M notional. Top 3 carry $268M.
Held by 283 ETFs · $5.5B across latest filings · largest weight 7.57% (EKG).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| QQQMInvesco NASDAQ 100 ETF | 0.12% | $121M | −0.03 pp |
| VHTVanguard Health Care ETF | 0.46% | $86M | +0.03 pp |
| SCHGSchwab U.S. Large-Cap Growth ETF | 0.10% | $61M | — |
| VONGVanguard Russell 1000 Growth ETF | 0.09% | $48M | −0.01 pp |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.32% |
| $41M |
| +0.30 pp |
| SCHXSchwab U.S. Large-Cap ETF | 0.04% | $30M | — |
| QGRO | 1.01% | $22M | new |
| MIGO | 2.93% | $22M | −1.22 pp |
| FWD | 0.76% | $22M | +0.05 pp |
| FNDA | 0.20% | $18M | +0.01 pp |
Showing 10 of 94 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DXCM Jan avg: 3.52% median: 3.92% win: 50% σ: 8.60% n: 4 2022-04-12 → 2026-07-31 | DXCM Feb avg: 0.20% median: 1.15% win: 75% σ: 3.81% n: 4 2022-04-12 → 2026-07-31 | DXCM Mar avg: -3.00% median: -4.91% win: 50% σ: 19.44% n: 4 2022-04-12 → 2026-07-31 | DXCM Apr avg: -4.28% median: -5.17% win: 40% σ: 9.11% n: 5 2022-04-12 → 2026-07-31 | DXCM May avg: 1.36% median: -3.36% win: 40% σ: 20.96% n: 5 2022-04-12 → 2026-07-31 | DXCM Jun avg: -0.36% median: 0.06% win: 60% σ: 6.89% n: 5 2022-04-12 → 2026-07-31 | DXCM Jul avg: -3.34% median: -3.07% win: 40% σ: 23.97% n: 5 2022-04-12 → 2026-07-31 | DXCM Aug avg: -5.81% median: -3.28% win: 50% σ: 9.55% n: 4 2022-04-12 → 2026-07-31 (current) | DXCM Sep avg: -5.91% median: -5.46% win: 0% σ: 3.98% n: 4 2022-04-12 → 2026-07-31 | DXCM Oct avg: 9.21% median: 0.17% win: 50% σ: 28.21% n: 4 2022-04-12 → 2026-07-31 | DXCM Nov avg: 11.50% median: 9.84% win: 75% σ: 13.94% n: 4 2022-04-12 → 2026-07-31 | DXCM Dec avg: 2.27% median: 2.14% win: 50% σ: 4.55% n: 4 2022-04-12 → 2026-07-31 |